Large-cell neuroendocrine tumors (NETs) are poorly differentiated malignancies of rare incidence and aggressive nature. NETs mostly arise in the lung followed by the gastrointestinal tract, although they are potentially ubiquitous throughout the body. Primary unknown NET has a worse prognosis and shorter survival comparing with other NETs, with limited available data in the literature concerning this subgroup. The authors report the case of large-cell NET with supraclavicular lymph node presentation. Total excisional biopsy revealed an enlarged adenopathy 18 × 15 × 10 mm, which was extensively infiltrated by a solid malignant neoplasm composed of large cells with granular chromatin, nuclear pseudo-inclusions, high mitotic index, and focal necrosis, with a Ki 67 index 25-30% and positive immunohistochemical study for the expression of cytokeratin 8/18, chromogranin, synaptophysin, and thyroid transcriptional factor-1 (TTF-1). There was no evidence of primary location apart from two infracentimetric lung lesions that could not be accessed for biopsy and were negative at both somatostatin receptor scintigraphy and positron emission tomography. The NET relapsed with three mediastinal masses, so the patient was started on chemotherapy with carboplatin and etoposide with initial total response. Early progression showed no response to further chemotherapy regimens (temozolomide, oral etoposide); therefore, the patient was treated with local radiotherapy. This patient has an atypical long survival (54 months) compared to the literature data. In fact, there are few long-term survivors of large-cell NET and they are all related to complete surgical resection.
YaoJC , HassanM , PhanA , et al . One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States . J Clin Oncol . 2008 ; 26 ( 18 ): 3063 - 72 . [https://doi.org/10.1200/JCO.2007.15.4377] . [PMID:18565894]
KlimstraDS , ModlinIR , CoppolaD , LloydRV , SusterS . The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems . Pancreas . 2010 ; 39 ( 6 ): 707 - 12 . [https://doi.org/10.1097/MPA.0b013e3181ec124e] . [PMID:20664470]
TravisWD , BrambillaE , NicholsonAG , et al . The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification . J Thorac Oncol . 2015 ; 10 ( 9 ): 1243 - 60 . [https://doi.org/10.1097/JTO.0000000000000630] . [PMID:26291008]
SotoDE , EisbruchA . Limited-stage extrapulmonary small-cell carcinoma: outcomes after modern chemotherapy and radiotherapy . Cancer J . 2007 ; 13 ( 4 ): 243 - 6 . [https://doi.org/10.1097/PPO.0b013e31813ffe7c] . [PMID:17762759]
KiEY , ParkJS , LeeKH , BaeSN , HurSY . Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature . World J Surg Oncol . 2014 ; 12 ( 1 ): 314 . [https://doi.org/10.1186/1477-7819-12-314] . [PMID:25314924]
TeradaT . Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies . Int J Clin Exp Pathol . 2013 ; 6 ( 6 ): 1177 - 9 . [PMID:23696939]
GrecoFA , VaughnWK , HainsworthJD . Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome . Ann Intern Med . 1986 ; 104 ( 4 ): 547 - 53 . [https://doi.org/10.7326/0003-4819-104-4-547] . [PMID:3006571]
HainsworthJD , JohnsonDH , GrecoFA . Poorly differentiated neuroendocrine carcinoma of unknown primary site (a newly recognized clinicopathologic entity) . Ann Intern Med . 1988 ; 109 ( 5 ): 364 - 71 . [https://doi.org/10.7326/0003-4819-109-5-364] . [PMID:2841895]
WangSC , ParekhJR , ZuraekMB , et al . Identification of unknown primary tumors in patients with neuroendocrine liver metastases . Arch Surg . 2010 ; 145 ( 3 ): 276 - 80 . [https://doi.org/10.1001/archsurg.2010.10] . [PMID:20231629]
YuanC , KeatingB , FarricielliLA , ZhangK . Large-cell neuroendocrine carcinoma (LCNEC) without pulmonary symptoms diagnosed in a cutaneous metastasis . Am J Case Rep . 2014 ; 15 : 97 - 102 . [https://doi.org/10.12659/AJCR.890094] . [PMID:24624250]
SchneiderKM , MartinezAY , GuglielmiM . Large cell neuroendocrine carcinoma: topic review and a unique case of metastasis to the mandible . J Maxillofac Oral Surg . 2015 ; 14 ( Suppl 1 ): 120 - 6 . [https://doi.org/10.1007/s12663-012-0362-x] . [PMID:25861184]
Boyar CetinkayaR , AagnesB , MyklebustTÅ , Thiis-EvensenE . Survival in neuroendocrine neoplasms: a report from a large Norwegian population-based study . Int J Cancer . 2018 ; 142 ( 6 ): 1139 - 47 . [https://doi.org/10.1002/ijc.31137] . [PMID:29082524]
SorbyeH , WelinS , LangerSW , et al . Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study . Ann Oncol . 2013 ; 24 ( 1 ): 152 - 60 . [https://doi.org/10.1093/annonc/mds276] . [PMID:22967994]
KoumarianouA , ChatzellisE , BoutziosG , TsavarisN , KaltsasG . Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas . Endokrynol Pol . 2013 ; 64 ( 1 ): 60 - 72 . [PMID:23450449]
PavelM , BaudinE , CouvelardA , et al . ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary . Neuroendocrinology . 2012 ; 95 ( 2 ): 157 - 76 . [https://doi.org/10.1159/000335597] . [PMID:22262022]
ObergK , AkerströmG , RindiG , JelicS . Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up . Ann Oncol . 2010 ; 21 ( Suppl 5 ): v223 - 7 . [https://doi.org/10.1093/annonc/mdq192] . [PMID:20555086]
CaplinME , PavelM , ĆwikłaJB , et al . Lanreotide in metastatic enteropancreatic neuroendocrine tumors . N Engl J Med . 2014 ; 371 ( 3 ): 224 - 33 . [https://doi.org/10.1056/NEJMoa1316158] . [PMID:25014687]
BerbariB , RomanoA , BhattiRet al. A case report of a poorly differentiated neuroendocrine carcinoma diagnosed in the bone marrow . Gastroenterol Hepatol Open Access. 2015 ; 3 ( 2 ): 73 .
KoumarianouA , KaltsasG , KulkeMH , et al . Temozolomide in advanced neuroendocrine neoplasms: pharmacological and clinical aspects . Neuroendocrinology . 2015 ; 101 ( 4 ): 274 - 88 . [https://doi.org/10.1159/000430816] . [PMID:25924937]
JungraithmayrW , KayserG , PasslickB , EggelingS . Neuroendocrine differentiation and neuroendocrine morphology at two different patterns in large-cell bronchial carcinomas: outcome after complete resection . World J Surg Oncol . 2006 ; 4 ( 1 ): 61 . [https://doi.org/10.1186/1477-7819-4-61] . [PMID:16953887]
KamiyoshiharaM , IbeT , IgaiH , et al . Roentgenological occult large-cell neuroendocrine carcinoma: report of a long-term survivor . Respir Med Case Rep. 2013 ; 8 : 14 - 7 . [https://doi.org/10.1016/j.rmcr.2012.12.00] . [PMID:26029607]
ShimonoC , SuwaK , SatoM , et al . Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment . Int J Clin Oncol . 2009 ; 14 ( 4 ): 351 - 5 . [https://doi.org/10.1007/s10147-008-0843-6] . [PMID:19705247]
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email